Marc Zemel is serial medical device entrepreneur and executive. He founded Retia Medical to develop advanced algorithms to help guide cardiovascular care for high-risk surgical and critically ill patients. In 2022, Retia closed its $15M Series B led by Fresenius and Medtronic and is now selling in 14 countries.